Zealand Pharma Loses Fifth of Value After Trial Dropouts
Danish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
Risk parity assigns capital to balance risk contributions across asset classes in retirement portfolios, aiming for steadier, more resilient returns.
26,821 articlesDanish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
The iShares Semiconductor ETF faces a pivotal year as AI-capex decisions by five hyperscalers set the pace. SOXX’s ne...
SoftBank Group stock tumbled about 20% over the past five trading days as questions surrounding OpenAI funding and th...
As SpaceX eyes a potential mega-IPO, a veteran market strategist says the issue could force a broad rotation, unlocki...
Brazilian officials say May deforestation hit a record low, even as the U.S. weighs new tariffs. The so-called 'trump...
Bezos-backed Prometheus closed a $12 billion private round, signaling a major push into AI-enabled industrial design ...
Homeowners hold trillions in tappable equity, yet tapping that wealth often requires debt. A new option, the home equ...
Coinbase and AWS unveiled a joint program allowing publishers on CloudFront and WAF to monetize AI-driven content acc...
SpaceX's IPO debut has turned into a high-velocity, meme-like run as investors chase a limited float. Crypto-linked f...
Trump’s truth social stake has fallen sharply while his golf properties surge, illustrating a two-track fortune in 2026.
Tesla’s AI ambitions are under the microscope as spending climbs and milestones approach. This report analyzes what i...
Taiwan Semiconductor Manufacturing Co. is trading at a valuation many investors describe as dirt cheap as AI-driven d...